Page last updated: 2024-08-23

piperacillin and Alloxan Diabetes

piperacillin has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arneric, SP; Bannon, AW; Campbell, JE; Decker, MW; Kim, DJ	1

Other Studies

1 other study(ies) available for piperacillin and Alloxan Diabetes

Article	Year
ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain. Brain research, 1998, Aug-10, Volume: 801, Issue:1-2 Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Azetidines; Cholinergic Antagonists; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Intraperitoneal; Ligation; Lumbosacral Region; Male; Morphine; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Spinal Nerves; Time Factors	1998

Article

Year

ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain.

Brain research, 1998, Aug-10, Volume: 801, Issue:1-2

Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Azetidines; Cholinergic Antagonists; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Intraperitoneal; Ligation; Lumbosacral Region; Male; Morphine; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Spinal Nerves; Time Factors

1998